Senior Regulatory Research Scientist
FDA/CDER/OPQ/OPQR
Maxwell Korang-Yeboah, Ph.D. is a Snr regulatory research scientist in the Office of Product Quality Research/OPQ/CDER/ US FDA. He serves as lead in regulatory research in lyophilization, complex drug products and characterization of peptides and proteins geared at advancing the scientific basis of review, policy, inspection, and guidance development. In addition, Maxwell serves as a subject matter expert in support of regulatory review, inspection, adoption of emerging technologies and risk assessment of freeze drying and alternate aseptic drying technologies. He is a member of OPQ’s Center of Excellence for Manufacturing Science and a subject matter expert for CDER’s Emerging Technology team. He is a recipient of a dozen FDA, CDER and OPQ regulatory research honor awards for his research contributions to the mission of the Agency. Maxwell is a well published scientist and has presented his work at several national and international scientific conferences and workshops
Disclosure information not submitted.
Symposium: AI/ML in Drug Discovery and Development
Thursday, May 16, 2024
9:30 AM – 11:00 AM PT
Mechanistic Insight into the Physical Stability of Oligonucleotides
Thursday, May 16, 2024
2:30 PM – 2:45 PM PT